IMRAN BAIG: Open Payments
NPI 1659659969 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,301 in 58 payments from 19 companies in 2025. Trend: 2023 $947 · 2024 $1,767 · 2025 $3,301
Food & beverage: $2,779Travel & lodging: $523
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $831 |
| Edwards Lifesciences Corporation | 5 | $699 |
| ABIOMED | 2 | $269 |
| Cleerly, Inc. | 4 | $256 |
| Novartis Pharmaceuticals Corporation | 13 | $217 |
| Penumbra, Inc. | 1 | $164 |
| Terumo Medical Corporation | 1 | $150 |
| AngioDynamics, Inc. | 4 | $126 |
| Abbott Laboratories | 2 | $124 |
| Shockwave Medical, Inc | 1 | $119 |
Products named: COREVALVE EVOLUT R, SAPIEN 3 Ultra RESILIA, Cleerly Ischemia, LEQVIO, Penumbra System, ANGIO-SEAL, ALPHAVAC, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter.
Industry payments across TX — which companies pay providers there.
